In an in vitro study, a single and combined treatment of MM cell lines RPMI8226/L-PAM and ARH-77/L-PAM with MEK inhibitors, PI3K inhibitors, and NF-κB inhibitors induced melphalan sensitization and markedly down-regulated the expression of HIF-1α.134. This evidence concerns the gene HIF1A and Miyoshi myopathy.